CliffBio
small molecule

TORNALATE

BITOLTEROL MESYLATE

Loss of exclusivity—loss of exclusivity
CompanySANOFI AVENTIS US LLC

Drug detail

Brand nameTORNALATE
Active ingredientBITOLTEROL MESYLATE
Strength0.37MG/INH
Dosage formAEROSOL, METERED
RouteINHALATION
ModalitySmall molecule
FDA approvalDecember 1984
Marketing statusDISCN

More from SANOFI AVENTIS US LLC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

TORNALATE patent cliff — loss of exclusivity — | CliffBio